GB0921731D0 - Theraputic uses - Google Patents

Theraputic uses

Info

Publication number
GB0921731D0
GB0921731D0 GBGB0921731.6A GB0921731A GB0921731D0 GB 0921731 D0 GB0921731 D0 GB 0921731D0 GB 0921731 A GB0921731 A GB 0921731A GB 0921731 D0 GB0921731 D0 GB 0921731D0
Authority
GB
United Kingdom
Prior art keywords
theraputic
theraputic uses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0921731.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Respivert Ltd
Original Assignee
Respivert Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Respivert Ltd filed Critical Respivert Ltd
Priority to GBGB0921731.6A priority Critical patent/GB0921731D0/en
Publication of GB0921731D0 publication Critical patent/GB0921731D0/en
Priority to UY0001033097A priority patent/UY33097A/en
Priority to PCT/GB2010/052066 priority patent/WO2011070368A1/en
Priority to TW099143134A priority patent/TW201130813A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
GBGB0921731.6A 2009-12-11 2009-12-11 Theraputic uses Ceased GB0921731D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB0921731.6A GB0921731D0 (en) 2009-12-11 2009-12-11 Theraputic uses
UY0001033097A UY33097A (en) 2009-12-11 2010-12-10 DERIVATIVES OF (1h-PIRAZOL-5-IL) UREIDOARILO 1,3-DISUSTITUIDOS AND ITS THERAPEUTIC USES
PCT/GB2010/052066 WO2011070368A1 (en) 2009-12-11 2010-12-10 Antiviral use of urea compounds
TW099143134A TW201130813A (en) 2009-12-11 2010-12-10 Therapeutic uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0921731.6A GB0921731D0 (en) 2009-12-11 2009-12-11 Theraputic uses

Publications (1)

Publication Number Publication Date
GB0921731D0 true GB0921731D0 (en) 2010-01-27

Family

ID=41666983

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0921731.6A Ceased GB0921731D0 (en) 2009-12-11 2009-12-11 Theraputic uses

Country Status (4)

Country Link
GB (1) GB0921731D0 (en)
TW (1) TW201130813A (en)
UY (1) UY33097A (en)
WO (1) WO2011070368A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8198279B2 (en) 2007-12-19 2012-06-12 Institute Of Cancer Research: Royal Cancer Hospital (The) Pyrido[2,3-b]pyrazin-8-substituted compounds and their use
GB0905955D0 (en) 2009-04-06 2009-05-20 Respivert Ltd Novel compounds
CA2786834C (en) 2010-02-01 2018-10-16 Cancer Research Technology Limited 1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
WO2011158044A2 (en) 2010-06-17 2011-12-22 Respivert Limited Respiratory formulations and compounds for use therein
GB201010196D0 (en) * 2010-06-17 2010-07-21 Respivert Ltd Methods
GB201010193D0 (en) 2010-06-17 2010-07-21 Respivert Ltd Medicinal use
EP2578582A1 (en) 2011-10-03 2013-04-10 Respivert Limited 1-Pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl)ureas as p38 MAP kinase inhibitors
EP2763984B1 (en) 2011-10-03 2016-04-20 Respivert Limited 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl)ureas as p38 map kinase inhibitors
WO2013083604A1 (en) 2011-12-09 2013-06-13 Chiesi Farmaceutici S.P.A. Kinase inhibitors
KR20140105459A (en) 2011-12-09 2014-09-01 키에시 파르마슈티시 엣스. 피. 에이. Kinase inhibitors
GB201214750D0 (en) 2012-08-17 2012-10-03 Respivert Ltd Compounds
GB201215357D0 (en) 2012-08-29 2012-10-10 Respivert Ltd Compounds
US20150210722A1 (en) 2012-08-29 2015-07-30 Respivert Limited Kinase inhibitors
WO2014033449A1 (en) 2012-08-29 2014-03-06 Respivert Limited Kinase inhibitors
EP2890695A2 (en) 2012-08-29 2015-07-08 Respivert Limited Kinase inhibitors
WO2014076484A1 (en) 2012-11-16 2014-05-22 Respivert Limited Kinase inhibitors
EP2970190A1 (en) 2013-03-14 2016-01-20 Respivert Limited Kinase inhibitors
WO2014162121A1 (en) 2013-04-02 2014-10-09 Topivert Pharma Limited Kinase inhibitors based upon n-alkyl pyrazoles
MX363949B (en) 2013-04-02 2019-04-08 Topivert Pharma Ltd Kinase inhibitor.
GB201320732D0 (en) 2013-11-25 2014-01-08 Cancer Rec Tech Ltd Methods of chemical synthesis
GB201320729D0 (en) 2013-11-25 2014-01-08 Cancer Rec Tech Ltd Therapeutic compounds and their use
EP3083604A1 (en) 2013-12-20 2016-10-26 Respivert Limited Urea derivatives useful as kinase inhibitors
TWI664967B (en) 2014-02-14 2019-07-11 英商瑞斯比維特有限公司 Novel compound
MA40775A (en) 2014-10-01 2017-08-08 Respivert Ltd 4- (4- (4-PHENYLUREIDO-NAPHTALÉN -1-YL) OXY-PYRIDIN-2-YL) AMINO-BENZOIC ACID USED AS A KINASE P38 INHIBITOR
EP3440073B1 (en) 2016-04-06 2022-06-08 Oxular Acquisitions Limited Kinase inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA73492C2 (en) 1999-01-19 2005-08-15 Aromatic heterocyclic compounds as antiinflammatory agents
JP4629978B2 (en) * 2002-02-25 2011-02-09 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 1,4-Disubstituted benzofused cycloalkylurea compounds useful for the treatment of cytokine-mediated diseases
EP1896449B1 (en) 2005-06-20 2013-11-06 Janssen R&D Ireland Heterocyclylaminoalkyl substituted benzimidazoles
ES2378704T3 (en) 2006-01-27 2012-04-17 Array Biopharma, Inc. Glucokinase activators
PL1979355T3 (en) 2006-01-30 2011-04-29 Irm Llc Spiro imidazole derivatives as ppar modulators
WO2007096764A2 (en) 2006-02-27 2007-08-30 Glenmark Pharmaceuticals S.A. Bicyclic heteroaryl derivatives as cannabinoid receptor modulators
JP5670912B2 (en) * 2008-12-11 2015-02-18 レスピバート・リミテツド p38 MAP kinase inhibitor

Also Published As

Publication number Publication date
UY33097A (en) 2011-06-30
WO2011070368A1 (en) 2011-06-16
TW201130813A (en) 2011-09-16

Similar Documents

Publication Publication Date Title
GB0921731D0 (en) Theraputic uses
DK3023438T3 (en) Anti-gitr-antistoffer
DK2457337T3 (en) Specialtilpasset impuls-burst
GB0919432D0 (en) Use
EP2462514A4 (en) Greenbooks
EP2515891A4 (en) 3-keto-n-propargyl-1-aminoindan
GB2482817B (en) Novel use
EP2519921A4 (en) Call-tracking
DK2464943T3 (en) Systemintegration
GB201207096D0 (en) ARadar
GB0922505D0 (en) Use
GB0905864D0 (en) Novel use
GB201014838D0 (en) Cable-raceways
GB0900319D0 (en) Hydrocharger
GB0917304D0 (en) Use
EP2510125A4 (en) Hyperprimers
AU4240P (en) Tuckerbox xTriticosecale
AU4926P (en) Bonscalib Scaevola aemula
AU4924P (en) Bonscablue Scaevola aemula
AU4925P (en) Bonscawi Scaevola aemula
GB0907472D0 (en) Use
GB0907963D0 (en) Use
GB0912237D0 (en) Use
GB0919888D0 (en) Use
GB0919586D0 (en) Use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)